When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...

17 clinical scenarios were developed for which amyloid or tau PET may be considered. Gil D. Rabinovici, M.D., from the University of California San Francisco, and colleagues updated AUC for ...

17 clinical scenarios developed for which amyloid or tau PET may be considered. (HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET ...

However, the degree and pattern of amyloid deposition were not correlated with cognitive deficits. In the past few years, hybrid imaging models have been widely accepted in clinical practice. The ...

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease MACHINE LEARNING MODEL USING ...

Objectives To explore whether regional tau binding measured at baseline is associated with the rapidity of Alzheimer’s disease (AD) progression over 2 years, as assessed by the decline in specified ...

Currently, although brain Abeta accumulation can be detected by positron emission tomography(4) (amyloid PET) and cerebrospinal fluid testing(5) (CSF testing), the high cost and invasiveness of ...

In related news, other scientists recently reported that phospho-tau isoforms in the CSF mirror protofibrillar forms of tau, ...

Researchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...